Premium
What happened to the HIV epidemic among non‐injecting drug users in New York City?
Author(s) -
Des Jarlais Don C.,
Arasteh Kamyar,
McKnight Courtney,
Feelemyer Jonathan,
Campbell Aimee N. C.,
Tross Susan,
Cooper Hannah L. F.,
Hagan Holly,
Perlman David C.
Publication year - 2017
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1111/add.13601
Subject(s) - heroin , medicine , demography , incidence (geometry) , confidence interval , logistic regression , human immunodeficiency virus (hiv) , drug , psychiatry , family medicine , physics , sociology , optics
Background and aims HIV has reached high prevalence in many non‐injecting drug user (NIDU) populations. The aims of this study were to (1) examine the trend in HIV prevalence among non‐injecting cocaine and heroin NIDUs in New York City, (2) identify factors potentially associated with the trend and (3) estimate HIV incidence among NIDUs. Design Serial‐cross sectional surveys of people entering drug treatment programs. People were permitted to participate only once per year, but could participate in multiple years. Setting Mount Sinai Beth Israel drug treatment programs in New York City, USA. Participants We recruited 3298 non‐injecting cocaine and heroin users from 2005 to 2014. Participants were 78.7% male, 6.1% white, 25.7% Hispanic and 65.8% African American. Smoking crack cocaine was the most common non‐injecting drug practice. Measures Trend tests were used to examine HIV prevalence, demographics, drug use, sexual behavior and use of antiretroviral treatment (ART) by calendar year; χ 2 and multivariable logistic regression were used to compare 2005–10 versus 2011–14. Findings HIV prevalence declined approximately 1% per year ( P < 0.001), with a decline from 16% in 2005–10 to 8% in 2011–14 ( P < 0.001). The percentages of participants smoking crack and having multiple sexual partners declined and the percentage of HIV‐positive people on ART increased. HIV incidence among repeat participants was 1.2 per 1000 person‐years (95% confidence interval = 0.03/1000–7/1000). Conclusions HIV prevalence has declined and a high percentage of HIV‐positive non‐injecting drug users (NIDUs) are receiving antiretroviral treatment, suggesting an end to the HIV epidemic among NIDUs in New York City. These results can be considered a proof of concept that it is possible to control non‐injecting drug use related sexual transmission HIV epidemics.